Journey Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.58M Buy
25,892
+695
+3% +$162K 0.5% 54
2026
Q1
$6.13M Sell
25,197
-2,799
-10% -$652K 0.52% 55
2025
Q4
$5.78M Buy
27,996
+3,122
+13% +$617K 0.49% 62
2025
Q3
$4.61M Sell
24,874
-1,363
-5% -$234K 0.34% 76
2025
Q2
$4.01M Sell
26,237
-262
-1% -$40.3K 0.31% 82
2025
Q1
$4.39M Sell
26,499
-3,707
-12% -$580K 0.36% 70
2024
Q4
$4.41M Hold
30,206
0.53% 58
2024
Q3
$4.41M Sell
30,206
-44
-0.1% -$7.01K 0.53% 58
2024
Q2
$4.42M Sell
30,250
-1,271
-4% -$189K 0.53% 58
2024
Q1
$4.99M Sell
31,521
-1,974
-6% -$314K 0.61% 45
2023
Q4
$5.25M Sell
33,495
-11,402
-25% -$1.75M 0.71% 38
2023
Q3
$6.99M Sell
44,897
-16,174
-26% -$2.67M 1.04% 27
2023
Q2
$10.1M Buy
61,071
+1,112
+2% +$179K 1.5% 16
2023
Q1
$9.29M Buy
59,959
+1,990
+3% +$321K 1.46% 18
2022
Q4
$10.2M Buy
57,969
+6,608
+13% +$1.14M 2.55% 6
2022
Q3
$8.39M Buy
51,361
+2,819
+6% +$477K 2.14% 8
2022
Q2
$8.44M Buy
48,542
+10,592
+28% +$1.89M 1.94% 8
2022
Q1
$6.73M Buy
37,950
+1,277
+3% +$217K 1.7% 11
2021
Q4
$6.27M Buy
36,673
+2,304
+7% +$377K 1.73% 11
2021
Q3
$5.55M Sell
34,369
-1,090
-3% -$186K 1.8% 12
2021
Q2
$5.84M Buy
35,459
+1,471
+4% +$244K 1.86% 12
2021
Q1
$5.59M Buy
33,988
+378
+1% +$61.2K 1.95% 12
2020
Q4
$5.29M Buy
+33,610
New +$4.96M 1.98% 12

Other funds holding JNJ

Journey Advisory Group's JNJ Position: Q2 2026 in Review

Journey Advisory Group increased its Johnson & Johnson (JNJ) stake by 2.8% in Q2 2026, buying an estimated $162K and bringing the position to 25,892 shares worth $6.58M. The position accounts for 0.5% of the portfolio, ranked #54.

Journey Advisory Group first reported a position in JNJ in Q4 2020 and has held it in 23 quarters since. The position peaked at $10.2M in Q4 2022. 3,015 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Journey Advisory Group held 25,892 shares of Johnson & Johnson worth $6.58M as of Q2 2026.
  • Journey Advisory Group bought 695 Johnson & Johnson shares in Q2 2026, an estimated $162K.
  • Johnson & Johnson made up 0.5% of Journey Advisory Group's portfolio in Q2 2026, its #54 holding.
  • Journey Advisory Group first reported a position in Johnson & Johnson in Q4 2020 and has held it in 23 quarters since.
  • Journey Advisory Group's Johnson & Johnson position peaked at $10.2M in Q4 2022.
  • 3,015 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Journey Advisory Group's 13F filing for Q2 2026, filed 4 Aug 2026.